{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:48:13Z","timestamp":1788814093528,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T00:00:00Z","timestamp":1704672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T00:00:00Z","timestamp":1704672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372760"],"award-info":[{"award-number":["82372760"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s00204-023-03669-z","type":"journal-article","created":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T13:02:21Z","timestamp":1704718941000},"page":"985-997","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Genome-wide functional integration identified MAZ-controlled RPS14 dysregulation in hepatocellular carcinoma"],"prefix":"10.1007","volume":"98","author":[{"given":"Linyu","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfei","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxiu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasha","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0310-5839","authenticated-orcid":false,"given":"Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,8]]},"reference":[{"issue":"17","key":"3669_CR1","doi-asserted-by":"publisher","first-page":"9960","DOI":"10.1093\/nar\/gkx641","volume":"45","author":"J \u00c1lvaro-Blanco","year":"2017","unstructured":"\u00c1lvaro-Blanco J, Urso K, Chiodo Y et al (2017) MAZ induces MYB expression during the exit from quiescence via the E2F site in the MYB promoter. Nucleic Acids Res 45(17):9960\u20139975. https:\/\/doi.org\/10.1093\/nar\/gkx641","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"3669_CR2","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.1093\/nar\/gkt127","volume":"41","author":"S Cogoi","year":"2013","unstructured":"Cogoi S, Zorzet S, Rapozzi V, G\u00e9ci I, Pedersen EB, Xodo LE (2013) MAZ-binding G4-decoy with locked nucleic acid and twisted intercalating nucleic acid modifications suppresses KRAS in pancreatic cancer cells and delays tumor growth in mice. Nucleic Acids Res 41(7):4049\u20134064. https:\/\/doi.org\/10.1093\/nar\/gkt127","journal-title":"Nucleic Acids Res"},{"issue":"13","key":"3669_CR3","doi-asserted-by":"publisher","first-page":"8379","DOI":"10.1093\/nar\/gku574","volume":"42","author":"S Cogoi","year":"2014","unstructured":"Cogoi S, Shchekotikhin AE, Xodo LE (2014) HRAS is silenced by two neighboring G-quadruplexes and activated by MAZ, a zinc-finger transcription factor with DNA unfolding property. Nucleic Acids Res 42(13):8379\u20138388. https:\/\/doi.org\/10.1093\/nar\/gku574","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"3669_CR4","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/s2468-1253(16)30018-8","volume":"1","author":"E Degasperi","year":"2016","unstructured":"Degasperi E, Colombo M (2016) Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease. Lancet Gastroenterol Hepatol 1(2):156\u2013164. https:\/\/doi.org\/10.1016\/s2468-1253(16)30018-8","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"12","key":"3669_CR5","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1016\/j.cellsig.2007.07.025","volume":"19","author":"J Fang","year":"2007","unstructured":"Fang J, Ding M, Yang L, Liu LZ, Jiang BH (2007) PI3K\/PTEN\/AKT signaling regulates prostate tumor angiogenesis. Cell Signal 19(12):2487\u20132497. https:\/\/doi.org\/10.1016\/j.cellsig.2007.07.025","journal-title":"Cell Signal"},{"issue":"7","key":"3669_CR6","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1158\/0008-5472.Can-06-4149","volume":"67","author":"Z Feng","year":"2007","unstructured":"Feng Z, Hu W, de Stanchina E et al (2007) The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways. Cancer Res 67(7):3043\u20133053. https:\/\/doi.org\/10.1158\/0008-5472.Can-06-4149","journal-title":"Cancer Res"},{"issue":"1","key":"3669_CR7","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.canlet.2016.03.004","volume":"375","author":"A G\u00f6bel","year":"2016","unstructured":"G\u00f6bel A, Thiele S, Browne AJ et al (2016) Combined inhibition of the mevalonate pathway with statins and zoledronic acid potentiates their anti-tumor effects in human breast cancer cells. Cancer Lett 375(1):162\u2013171. https:\/\/doi.org\/10.1016\/j.canlet.2016.03.004","journal-title":"Cancer Lett"},{"issue":"5","key":"3669_CR8","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1002\/hep.24799","volume":"55","author":"L Hu","year":"2012","unstructured":"Hu L, Zhai X, Liu J et al (2012) Genetic variants in human leukocyte antigen\/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development. Hepatology 55(5):1426\u20131431. https:\/\/doi.org\/10.1002\/hep.24799","journal-title":"Hepatology"},{"issue":"1","key":"3669_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2022.113451","volume":"423","author":"S Hu","year":"2023","unstructured":"Hu S, Cai J, Fang H, Chen Z, Zhang J, Cai R (2023) RPS14 promotes the development and progression of glioma via p53 signaling pathway. Exp Cell Res 423(1):113451. https:\/\/doi.org\/10.1016\/j.yexcr.2022.113451","journal-title":"Exp Cell Res"},{"issue":"1","key":"3669_CR10","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/ng.2483","volume":"45","author":"DK Jiang","year":"2013","unstructured":"Jiang DK, Sun J, Cao G et al (2013a) Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma. Nat Genet 45(1):72\u201375. https:\/\/doi.org\/10.1038\/ng.2483","journal-title":"Nat Genet"},{"issue":"12","key":"3669_CR11","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201910835","volume":"11","author":"H Li","year":"2019","unstructured":"Li H, Yang F, Hu A et al (2019) Therapeutic targeting of circ-CUX1\/EWSR1\/MAZ axis inhibits glycolysis and neuroblastoma progression. EMBO Mol Med 11(12):e10835. https:\/\/doi.org\/10.15252\/emmm.201910835","journal-title":"EMBO Mol Med"},{"key":"3669_CR12","doi-asserted-by":"publisher","unstructured":"Li S, Qian J, Yang Y, et al. (2012) GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers. PLoS Genet 8(7):e1002791 https:\/\/doi.org\/10.1371\/journal.pgen.1002791","DOI":"10.1371\/journal.pgen.1002791"},{"key":"3669_CR13","doi-asserted-by":"publisher","unstructured":"Li Y, Zhai Y, Song Q, et al. (2018) Genome-Wide Association Study Identifies a New Locus at 7q21.13 Associated with Hepatitis B Virus-Related Hepatocellular Carcinoma. Clin Cancer Res 24(4):906\u2013915 https:\/\/doi.org\/10.1158\/1078-0432.Ccr-17-2537","DOI":"10.1158\/1078-0432.Ccr-17-2537"},{"issue":"5","key":"3669_CR14","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1007\/s00204-021-03021-3","volume":"95","author":"J Liu","year":"2021","unstructured":"Liu J, Wang D, Zhou J et al (2021) N6-methyladenosine reader YTHDC2 and eraser FTO may determine hepatocellular carcinoma prognoses after transarterial chemoembolization. Arch Toxicol 95(5):1621\u20131629. https:\/\/doi.org\/10.1007\/s00204-021-03021-3","journal-title":"Arch Toxicol"},{"issue":"11","key":"3669_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1107","volume":"12","author":"J Liu","year":"2022","unstructured":"Liu J, Zhang N, Zeng J et al (2022) N(6) -methyladenosine-modified lncRNA ARHGAP5-AS1 stabilises CSDE1 and coordinates oncogenic RNA regulons in hepatocellular carcinoma. Clin Transl Med 12(11):e1107. https:\/\/doi.org\/10.1002\/ctm2.1107","journal-title":"Clin Transl Med"},{"key":"3669_CR16","doi-asserted-by":"publisher","unstructured":"Llovet JM, Kelley RK, Villanueva A, et al. (2021) Hepatocellular carcinoma. Nat Rev Disease Primers 7(1):6 https:\/\/doi.org\/10.1038\/s41572-020-00240-3","DOI":"10.1038\/s41572-020-00240-3"},{"issue":"1","key":"3669_CR17","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13046-019-1154-7","volume":"38","author":"A Lopes","year":"2019","unstructured":"Lopes A, Vandermeulen G, Pr\u00e9at V (2019) Cancer DNA vaccines: current preclinical and clinical developments and future perspectives. J Exp Clin Cancer Res 38(1):146. https:\/\/doi.org\/10.1186\/s13046-019-1154-7","journal-title":"J Exp Clin Cancer Res"},{"issue":"12","key":"3669_CR18","doi-asserted-by":"publisher","first-page":"4334","DOI":"10.1074\/jbc.RA117.000333","volume":"293","author":"G Maity","year":"2018","unstructured":"Maity G, Haque I, Ghosh A et al (2018) The MAZ transcription factor is a downstream target of the oncoprotein Cyr61\/CCN1 and promotes pancreatic cancer cell invasion via CRAF-ERK signaling. J Biol Chem 293(12):4334\u20134349. https:\/\/doi.org\/10.1074\/jbc.RA117.000333","journal-title":"J Biol Chem"},{"key":"3669_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.canlet.2017.05.001","volume":"402","author":"K Mima","year":"2017","unstructured":"Mima K, Nakagawa S, Sawayama H et al (2017) The microbiome and hepatobiliary-pancreatic cancers. Cancer Lett 402:9\u201315. https:\/\/doi.org\/10.1016\/j.canlet.2017.05.001","journal-title":"Cancer Lett"},{"key":"3669_CR20","doi-asserted-by":"publisher","unstructured":"Ren LX, Qi JC, Zhao AN, et al. (2021) Myc-associated zinc-finger protein promotes clear cell renal cell carcinoma progression through transcriptional activation of the MAP2K2-dependent ERK pathway. Cancer Cell International 21(1) https:\/\/doi.org\/10.1186\/s12935-021-02020-9","DOI":"10.1186\/s12935-021-02020-9"},{"issue":"1","key":"3669_CR21","doi-asserted-by":"publisher","first-page":"7958","DOI":"10.1038\/s41598-018-26217-7","volume":"8","author":"H Sawai","year":"2018","unstructured":"Sawai H, Nishida N, Khor SS et al (2018) Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma. Sci Rep 8(1):7958. https:\/\/doi.org\/10.1038\/s41598-018-26217-7","journal-title":"Sci Rep"},{"issue":"4","key":"3669_CR22","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1158\/0008-5472.Can-22-1923","volume":"83","author":"Y Shen","year":"2023","unstructured":"Shen Y, Zhang N, Chai J et al (2023) CircPDIA4 induces gastric cancer progression by promoting erk1\/2 activation and enhancing biogenesis of oncogenic circRNAs. Cancer Res 83(4):538\u2013552. https:\/\/doi.org\/10.1158\/0008-5472.Can-22-1923","journal-title":"Cancer Res"},{"issue":"8","key":"3669_CR23","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1101\/gad.973602","volume":"16","author":"B Singh","year":"2002","unstructured":"Singh B, Reddy PG, Goberdhan A et al (2002) p53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomas. Genes Dev 16(8):984\u2013993. https:\/\/doi.org\/10.1101\/gad.973602","journal-title":"Genes Dev"},{"issue":"6","key":"3669_CR24","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1096\/fj.11-202820","volume":"26","author":"M Smits","year":"2012","unstructured":"Smits M, Wurdinger T, van het Hof B et al (2012) Myc-associated zinc finger protein (MAZ) is regulated by miR-125b and mediates VEGF-induced angiogenesis in glioblastoma. FASEB 26(6):2639\u20132647. https:\/\/doi.org\/10.1096\/fj.11-202820","journal-title":"FASEB"},{"issue":"9","key":"3669_CR25","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1007\/s00204-021-03119-8","volume":"95","author":"Y Song","year":"2021","unstructured":"Song Y, Xing H, Zhou L, Zhang N, Yang M (2021) LncRNA H19 modulated by miR-146b-3p\/miR-1539-mediated allelic regulation in transarterial chemoembolization of hepatocellular carcinoma. Arch Toxicol 95(9):3063\u20133070. https:\/\/doi.org\/10.1007\/s00204-021-03119-8","journal-title":"Arch Toxicol"},{"key":"3669_CR26","doi-asserted-by":"publisher","unstructured":"Sung H, Ferlay J, Siegel RL, et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: a cancer journal for clinicians 71(3):209\u2013249 https:\/\/doi.org\/10.3322\/caac.21660","DOI":"10.3322\/caac.21660"},{"issue":"4","key":"3669_CR27","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1179\/1607845413y.0000000127","volume":"19","author":"L Wang","year":"2014","unstructured":"Wang L, Luo J, Nian Q, Xiao Q, Yang Z, Liu L (2014) Ribosomal protein S14 silencing inhibits growth of acute myeloid leukemia transformed from myelodysplastic syndromes via activating p53. Hematology (amsterdam, Netherlands) 19(4):225\u2013231. https:\/\/doi.org\/10.1179\/1607845413y.0000000127","journal-title":"Hematology (amsterdam, Netherlands)"},{"issue":"10","key":"3669_CR28","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1097\/cad.0000000000001112","volume":"32","author":"X Wang","year":"2021","unstructured":"Wang X, Yao S, Luo G, Zhou Y, Fang Q (2021) Downregulation of RPS14 inhibits the proliferation and metastasis of estrogen receptor-positive breast cancer cells. Anticancer Drugs 32(10):1019\u20131028. https:\/\/doi.org\/10.1097\/cad.0000000000001112","journal-title":"Anticancer Drugs"},{"key":"3669_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109660","volume":"115","author":"M Wang","year":"2023","unstructured":"Wang M, Yang X, Meng Y et al (2023) Comprehensive analysis of the tumor-promoting effect and immune infiltration correlation MAZ from pan-cancer to hepatocellular carcinoma. Int Immunopharmacol 115:109660. https:\/\/doi.org\/10.1016\/j.intimp.2022.109660","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"3669_CR30","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/cm9.0000000000002108","volume":"135","author":"C Xia","year":"2022","unstructured":"Xia C, Dong X, Li H et al (2022) Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J 135(5):584\u2013590. https:\/\/doi.org\/10.1097\/cm9.0000000000002108","journal-title":"Chin Med J"},{"issue":"2","key":"3669_CR31","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ajhg.2016.05.029","volume":"99","author":"X Yang","year":"2016","unstructured":"Yang X, Yu D, Ren Y et al (2016) Integrative functional genomics implicates EPB41 dysregulation in hepatocellular carcinoma risk. Am J Hum Genet 99(2):275\u2013286. https:\/\/doi.org\/10.1016\/j.ajhg.2016.05.029","journal-title":"Am J Hum Genet"},{"key":"3669_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2019.113772","volume":"172","author":"N Zhang","year":"2020","unstructured":"Zhang N, Li Y, Xie M et al (2020a) DACT2 modulated by TFAP2A-mediated allelic transcription promotes EGFR-TKIs efficiency in advanced lung adenocarcinoma. Biochem Pharmacol 172:113772. https:\/\/doi.org\/10.1016\/j.bcp.2019.113772","journal-title":"Biochem Pharmacol"},{"issue":"20","key":"3669_CR33","doi-asserted-by":"publisher","first-page":"9378","DOI":"10.7150\/thno.48247","volume":"10","author":"N Zhang","year":"2020","unstructured":"Zhang N, Song Y, Xu Y et al (2020b) MED13L integrates Mediator-regulated epigenetic control into lung cancer radiosensitivity. Theranostics 10(20):9378\u20139394. https:\/\/doi.org\/10.7150\/thno.48247","journal-title":"Theranostics"},{"key":"3669_CR34","doi-asserted-by":"publisher","first-page":"0184","DOI":"10.34133\/research.0184","volume":"6","author":"H Zhang","year":"2023","unstructured":"Zhang H, Zhai X, Liu Y et al (2023a) NOP2-mediated m5C modification of c-Myc in an EIF3A-dependent manner to reprogram glucose metabolism and promote hepatocellular carcinoma progression. Research (washington, DC) 6:0184. https:\/\/doi.org\/10.34133\/research.0184","journal-title":"Research (washington, DC)"},{"key":"3669_CR35","doi-asserted-by":"publisher","unstructured":"Zhang H, Zhai Y, Hu Z, et al. (2010) Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers. Nat Genet 42(9):755\u20138 https:\/\/doi.org\/10.1038\/ng.638","DOI":"10.1038\/ng.638"},{"key":"3669_CR36","doi-asserted-by":"publisher","unstructured":"Zhang N, Wang B, Ma C, et al. (2023b) LINC00240 in the 6p22.1 risk locus promotes gastric cancer progression through USP10-mediated DDX21 stabilization. J Exp Clin Cancer Res 42(1):89 https:\/\/doi.org\/10.1186\/s13046-023-02654-9","DOI":"10.1186\/s13046-023-02654-9"},{"key":"3669_CR37","doi-asserted-by":"publisher","unstructured":"Zheng Y, Lei T, Jin G, et al. (2021) LncPSCA in the 8q24.3 risk locus drives gastric cancer through destabilizing DDX5. Embo Rep 22(11):e52707 https:\/\/doi.org\/10.15252\/embr.202152707","DOI":"10.15252\/embr.202152707"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-023-03669-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-023-03669-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-023-03669-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T21:12:58Z","timestamp":1708031578000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-023-03669-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,8]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["3669"],"URL":"https:\/\/doi.org\/10.1007\/s00204-023-03669-z","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,8]]},"assertion":[{"value":"24 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}